BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
HEIDELBERG, Germany, August 1, 2022 / B3C newswire / -- BioMed X,
a German independent research institute, announces the start of its new
research project ‘Extrachromosomal DNA in Cancer’ (EDC) in
collaboration with Healthcare Business of Merck KGaA, Darmstadt,
Germany. The main objective of this research group is to develop an
atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and
thereby trace back the mechanisms of ecDNA formation and function.
More info >> |